Advertisement

Scleroderma

  • Elena SchiopuEmail author
  • James R. Seibold
Chapter

Abstract

Scleroderma is a descriptive construct that defines a large family of ­diseases characterized clinically by thickening of the skin. Systemic sclerosis (SSc) is a complex disease affecting multiple organ systems and is the most ­representative and prevalent of this spectrum of disorders. Generalized subcutaneous morphea (GSM, morphea profunda) is a form of localized scleroderma that tends to spare the internal organs. We are presenting two cases illustrating the aforementioned clinical entities.

Keywords

Scleroderma Fibrosing disorders Morphea 

References

  1. 1.
    Artlett, C., Microchimerism and Scleroderma: An Update. Current Rheumatology Reports, 2003. 5: p. 154–9.PubMedCrossRefGoogle Scholar
  2. 2.
    Varga, J. and D. Abraham, Systemic sclerosis: A prototypic multisystem fibrotic disorder. Journal of Clinical Investigation, 2007. 117(3): p. 557–67.PubMedCrossRefGoogle Scholar
  3. 3.
    Kahaleh, M., Raynaud phenomenon and the vascular disease in scleroderma. Current Opinion in Rheumatology, 2004. 16: p. 718–22.PubMedCrossRefGoogle Scholar
  4. 4.
    LeRoy, E., et al., Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis. Journal of Rheumatology, 1988. 15(2): p. 202–5.PubMedGoogle Scholar
  5. 5.
    Denton, C. and J. Korn, Digital ulceration and critical digital ischaemia in scleroderma. Scleroderma Care and Research Journal, 2003. 1: p. 12–6.Google Scholar
  6. 6.
    Steen, V. and T. Medsger, Changes in causes of death in systemic sclerosis, 1972–2002. Annals of Rheumatic Diseases, 2007. 66: p. 940–4.CrossRefGoogle Scholar
  7. 7.
    Steen, V., et al., Isolated diffusing capacity reduction in systemic sclerosis. Arthritis and Rheumatism, 1992. 35(7): p. 765–70.PubMedCrossRefGoogle Scholar
  8. 8.
    Tashkin, D., et al., Cyclophosphamide versus placebo in scleroderma lung disease. New England Journal of Medicine, 2006. 25(354): p. 2655–66.CrossRefGoogle Scholar
  9. 9.
    Zamora, A., et al., Use of mycophenolate mofetil to treat scleroderma-associated interstitial lung disease. Respiratory Medicine, 2008. 1(102): p. 150–5.CrossRefGoogle Scholar
  10. 10.
    Nihtyanova, S., C. Black, and C. Denton, Mycophenolate mofetil in diffuse cutaneous systemic sclerosis – A retrospective analysis. Rheumatology, 2007. 3(46): p. 442–5.CrossRefGoogle Scholar
  11. 11.
    Peterson, L., A. Nelson, and W. Su, Classification of morphea (localized scleroderma). Mayo Clinic Proceedings, 1995. 70: p. 1068–76.PubMedCrossRefGoogle Scholar
  12. 12.
    Person, J. and W. Su, Subcutaneous morphoea: A clinical study of sixteen cases. British Journal of Dermatology, 1979. 100: p. 371–80.PubMedCrossRefGoogle Scholar
  13. 13.
    Dehen, L., et al., Internal involvement in localized scleroderma. Medicine (Baltimore), 1994. 73(5): p. 241–5.Google Scholar
  14. 14.
    Postlethwaite, A., et al., Human fibroblasts synthesize elevated levels of extracellular matrix proteins in response to interleukin 4. Journal of Clinical Investigation, 1992. 90(4): p. 1479–85.PubMedCrossRefGoogle Scholar
  15. 15.
    Igarashi, A., et al., Connective tissue growth factor gene expression in tissue sections from localized scleroderma, keloid, and other fibrotic skin disorders. Journal of Investigational Dermatology, 1996. 106(4): p. 729–33.CrossRefGoogle Scholar
  16. 16.
    Uziel, Y., et al., Methotrexate and corticosteroid therpay for pediatric localized scleroderma. Journal of Pediatrics, 2000. 136: p. 91–5.PubMedCrossRefGoogle Scholar
  17. 17.
    Grundman-Kollmann, M., et al., PUVA-cream photochemotherapy for the treatment of localized scleroderma. Journal of the American Academy of Dermatology, 2000. 43(4): p. 675–8.CrossRefGoogle Scholar
  18. 18.
    Martini, G., et al., Successful treatment of severe or methotrexate-resistant juvenile localized scleroderma with mycophenolate mofetil. Rheumatology, 2009. 48(11): p. 1410–3.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.Division of RheumatologyUniversity of MichiganAnn ArborUSA

Personalised recommendations